insights_auto
Outlook: 63.2% bullish·0.0% bearish
Go to analysischevron_right
RVMD:NASDAQ
Revolution Medicines Inc
$191.02
arrow_upward
+1.54%(+2.90) 1D
Oct 9, 3:19:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 23 analysts giving stock ratings to RVMD in the past 3 months
Strong buy
Buy
22
Hold
1
Sell
0
12-month forecast
Based on 23 Wall Street analysts offering 12 month price targets for RVMD in the last 3 months.
Highest
Current $191.02
$320.00 (+67.52%)
Average
$258.62 (+35.39%)
Lowest
$179.00 (-6.29%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Michael Schmidt Guggenheim | Buy | Maintained | $275.00 | +44% | 10/08/2026 |
Alec Stranahan Bank of America Securities | Buy | Maintained | $264.00 | +38.2% | 10/09/2026 |
Tyler Van Buren TD Cowen | Buy | Maintained | - | - | 10/08/2026 |
Laura Prendergast Stifel Nicolaus | Buy | Maintained | - | - | 10/08/2026 |
Leonid Timashev RBC Capital | Buy | Maintained | $259.00 | +35.6% | 10/08/2026 |
Gregory Renza Truist Financial | Buy | Maintained | $240.00 | +25.6% | 10/07/2026 |
Charles Zhu LifeSci Capital | Buy | Maintained | $315.00 | +64.9% | 10/05/2026 |
Leah R. Cann Brookline Capital Markets | Buy | Initiated | $318.00 | +66.5% | 09/28/2026 |
Jeffrey Walch Bernstein | Hold | Maintained | $179.00 | -6.3% | 09/25/2026 |
Andrea Newkirk Goldman Sachs | Buy | Initiated | $267.00 | +39.8% | 09/24/2026 |
Sean Laaman Morgan Stanley | Buy | Initiated | $255.00 | +33.5% | 09/10/2026 |
Faisal Khurshid Jefferies | Buy | Maintained | $270.00 | +41.3% | 09/03/2026 |
Brian Cheng J.P. Morgan | Buy | Maintained | $246.00 | +28.8% | 09/01/2026 |
Ami Fadia Needham | Buy | Reiterated | $275.00 | +44% | 08/31/2026 |
Michael Yee UBS | Buy | Maintained | $265.00 | +38.7% | 08/28/2026 |
Sean McCutcheon Raymond James | Buy | Maintained | $248.00 | +29.8% | 08/27/2026 |
Jay Olson Oppenheimer | Buy | Maintained | $260.00 | +36.1% | 08/27/2026 |
Cory Kasimov Evercore ISI | Buy | Maintained | $320.00 | +67.5% | 08/27/2026 |
Eva Fortea Verdejo Wells Fargo | Buy | Reiterated | $240.00 | +25.6% | 08/27/2026 |
Robert Burns H.C. Wainwright | Buy | Reiterated | $280.00 | +46.6% | 08/27/2026 |
Robert Driscoll Wedbush | Buy | Maintained | $225.00 | +17.8% | 08/27/2026 |
Kalpit Patel Wolfe Research | Buy | Maintained | $220.00 | +15.2% | 08/10/2026 |
Marc Frahm TD Cowen | Buy | Reiterated | - | - | 08/10/2026 |
Joseph Catanzaro Mizuho Securities | Buy | Reiterated | $215.00 | +12.6% | 08/05/2026 |
Kelsey Goodwin Piper Sandler | Buy | Maintained | $210.00 | +9.9% | 08/06/2026 |
Unknown Analyst Bernstein | Hold | Maintained | $151.00 | -21% | 06/07/2026 |
Michael Morris Guggenheim | Buy | Maintained | $175.00 | -8.4% | 04/22/2026 |
Jonathan Chang Leerink Partners | Buy | Reiterated | $147.00 | -23% | 04/13/2026 |
Asthika Goonewardene Truist Financial | Buy | Maintained | - | - | 03/09/2026 |